D. Western Therapeutics Institute, Inc. (TYO:4576)

TYO:4576 Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,799	8,226	4,530	7,998	6,341	8,454
Market Cap Growth	81.59%	81.59%	-43.36%	26.13%	-24.98%	-50.43%
Enterprise Value	4,470	8,125	3,321	6,755	4,779	6,542
Last Close Price	106.00	201.00	141.00	262.00	216.00	289.00
PS Ratio	10.19	17.47	10.58	17.85	15.32	23.81
PB Ratio	6.55	11.22	3.54	4.28	3.12	3.91
P/TBV Ratio	6.97	11.94	3.80	4.62	3.45	4.32
EV/Sales Ratio	9.49	17.25	7.76	15.08	11.55	18.43
EV/FCF Ratio	-3.42	-	-	-	-	-
Debt / Equity Ratio	1.09	1.09	0.69	0.52	0.17	0.21
Asset Turnover	0.23	0.23	0.16	0.17	0.16	0.15
Inventory Turnover	0.50	0.50	0.43	0.34	0.29	0.29
Quick Ratio	9.48	9.48	10.23	11.87	10.54	11.48
Current Ratio	11.17	11.17	11.02	12.60	11.20	11.98
Return on Equity (ROE)	-128.23%	-128.23%	-52.51%	-22.59%	-7.62%	-16.30%
Return on Assets (ROA)	-37.42%	-37.42%	-18.72%	-7.06%	-4.13%	-7.05%
Return on Capital (ROIC)	-40.96%	-40.96%	-19.95%	-7.34%	-4.30%	-7.37%
Earnings Yield	-26.88%	-15.68%	-17.93%	-5.36%	-2.33%	-3.26%
FCF Yield	-27.25%	-15.90%	-13.20%	-4.54%	-2.81%	-2.61%
Buyback Yield / Dilution	-10.51%	-10.51%	-7.22%	-1.04%	-7.96%	-3.41%

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.